These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4635741)

  • 21. The use of estrogens as postcoital contraceptive agents. Clinical effectiveness and potential mode of action.
    Blye RP
    Am J Obstet Gynecol; 1973 Aug; 116(7):1044-50. PubMed ID: 4577932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation effects of oral contraception.
    Bonnar J
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of chlorotrianisene as postpartum lactation suppression on blood coagulation factors.
    Niebyl JR; Bell WR; Schaaf ME; Blake DA; Dubin NH; King TM
    Am J Obstet Gynecol; 1979 Jul; 134(5):518-22. PubMed ID: 453287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of lactation comparing stilboestrol and bromocriptine (CB154).
    Ladipo OA; Ojo OA
    Niger Med J; 1979 Jan; 9(1):77-9. PubMed ID: 463344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The change of antithrombin III activity of pregnant women and women on oral contraceptives (author's transl)].
    Ogura H; Miyaji K; Kinoshita T; Aoki N
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):232-7. PubMed ID: 578068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraceptive needs of breast-feeding women.
    Family Health International FHI
    Netw Res Triangle Park N C; 1986; 8(1):1-2, 5, 8. PubMed ID: 12268486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives and antithrombin III: variations by dosage and ABO blood group.
    Burkman RT; Bell WR; Zacur HA; Kimball AW
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1453-8; discussion 1458-60. PubMed ID: 2048592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies of the estrogenic potency of mestranol and stilbestrol].
    Teter J; Krzywdziński K
    Ginekol Pol; 1971; 42(3):351-8. PubMed ID: 5554647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Family planning during breast feeding].
    Peralta O; Díaz S; Croxatto H
    Rev Chil Pediatr; 1989; 60 Suppl 2():19-23. PubMed ID: 2519785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin inhibitors in women on oral contraceptives.
    Guagnellini E; Bertolini G; Cappelletti M; Colombo G
    Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraceptives, blood clotting and thrombosis.
    Poller L
    Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
    Mink IB; Courey NG; Niswander KR; Moore RH; Lillie MA; Ambrus JL
    Am J Obstet Gynecol; 1974 Jun; 119(3):401-5. PubMed ID: 4275088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives in the puerperium.
    Sulak PJ
    Int J Fertil; 1991; 36 Suppl 2():87-9. PubMed ID: 1679422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antithrombin 3 changes in women using oral contraceptives].
    Conard J; Salomon Y; Samama M
    Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestational agents and blood coagulation. VIII. Effect of low-dose, alternate-day, estrogen-progestin combinations on blood coagulation factors in man, with a special note on the effect of freezing of blood samples.
    Ambrus JL; Courey NG; Browne BJ; Mink IB; Moore RH; Ambrus CM
    Am J Obstet Gynecol; 1977 May; 128(2):161-6. PubMed ID: 857675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.